PREDICTION OF RESPONSE TO INTERFERON THERAPY BY SERUM LEVELS OF TYPE-IV COLLAGEN AND PROLYL HYDROXYLASE IN CHRONIC HEPATITIS-C

被引:0
作者
MIYABAYASHI, C
HIGUCHI, K
AIBA, N
SHIMIZU, Y
NAMBU, S
TAKAHARA, T
WATANABE, A
机构
[1] The Third Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, 930-01
来源
INTERNATIONAL HEPATOLOGY COMMUNICATIONS | 1994年 / 2卷 / 03期
关键词
TYPE-IV COLLAGEN; PROLYL HYDROXYLASE; INTERFERON; CHRONIC HEPATITIS-C;
D O I
10.1016/0928-4346(94)90049-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We evaluated histological activity index (HAI) score and serum markers of liver fibrosis, type IV collagen (IV-C) and prolyl hydroxylase (PH), to analyze whether they are predictors of response to interferon (IFN) treatment for chronic hepatitis C. Efficacy of IFN therapy was evaluated in 16 patients. Mean serum levels of IV-C and PH before treatment in five responders were lower than those in 11 non-responders (not significant). Among seven patients whose IV-C values were less than 200 ng/ml and PH less than 80 ng/ml, five patients (71.4%) were responders. The response rate of these seven patients was significantly (P < 0.005) higher than that (0%) in the other nine patients. When patients were histologically divided by the total HAI scores, the response rate to IFN in patients with low HAI score (10 or less) was 71.4% (five of seven patients), while that in patients with high HAI score (more than 10) was 0%. The result that the response rate to IFN in patients with low serum IV-C and PH levels equaled that in patients with low HAI score suggests that the efficacy of IFN treatment may be predictable by measuring serum levels of IV-C and PH in patients with chronic hepatitis C.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 50 条
  • [41] Significance of early measurement of serum hepatitis C virus RNA in predicting response to interferon therapy in patients with chronic hepatitis C
    Toyoda, H
    Kumada, T
    Nakano, S
    Takeda, I
    Sugiyama, K
    Kiriyama, S
    Sone, Y
    Miyata, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (03) : 245 - 249
  • [42] ARTHRITIS IN A PATIENT WITH PSORIASIS AFTER INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-C
    MAKINO, Y
    TANAKA, H
    NAKAMURA, K
    FUJITA, M
    AKIYAMA, K
    MAKINO, I
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (09) : 1771 - 1772
  • [43] CHANGES OF SERUM 2',5'-OLIGOADENYLATE SYNTHETASE-ACTIVITY DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS-C
    SOLINAS, A
    COSSU, P
    PODDIGHE, P
    TOCCO, A
    DEPLANO, A
    GARRUCCIU, G
    DIANA, MSA
    LIVER, 1993, 13 (05): : 253 - 258
  • [44] LICHEN-PLANUS AFTER ALPHA-INTERFERON THERAPY FOR CHRONIC HEPATITIS-C
    DUPIN, N
    CHOSIDOW, O
    FRANCES, C
    BOISNIC, S
    LUNELFABIANI, F
    OPOLON, P
    HERSON, S
    EUROPEAN JOURNAL OF DERMATOLOGY, 1994, 4 (07) : 535 - 536
  • [45] THE EFFECT OF INTERFERON-ALPHA AND PREDNISOLONE ON THE SERUM CONCENTRATIONS OF THE AMINOTERMINAL DOMAIN OF PROCOLLAGEN TYPE-III(PIIIP) AND TYPE-IV (7-S COLLAGEN) IN PATIENTS WITH CHRONIC HEPATITIS-B
    HAYASAKA, A
    KOHEN, H
    YOSHIKAWA, N
    IIDA, S
    OHTO, M
    JOURNAL OF HEPATOLOGY, 1993, 19 (01) : 36 - 42
  • [46] Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
    Satoshi Mamori
    Fumitaka Suzuki
    Tetsuya Hosaka
    Norio Akuta
    Takashi Someya
    Masahiro Kobayashi
    Akihito Tsubota
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 776 - 782
  • [47] Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
    Yasushi Tamura
    Satoshi Yamagiwa
    Yohei Aoki
    So Kurita
    Takeshi Suda
    Shogo Ohkoshi
    Minoru Nomoto
    Yutaka Aoyagi
    Digestive Diseases and Sciences, 2009, 54 : 2530 - 2537
  • [48] Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C
    Murawaki, Y
    Koda, M
    Okamoto, K
    Mimura, K
    Kawasaki, H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (07) : 777 - 781
  • [49] Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
    Mamori, S
    Suzuki, F
    Hosaka, T
    Akuta, N
    Someya, T
    Kobayashi, M
    Tsubota, A
    Suzuki, Y
    Saitoh, S
    Arase, Y
    Ikeda, K
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (08) : 776 - 782
  • [50] Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
    Tamura, Yasushi
    Yamagiwa, Satoshi
    Aoki, Yohei
    Kurita, So
    Suda, Takeshi
    Ohkoshi, Shogo
    Nomoto, Minoru
    Aoyagi, Yutaka
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (11) : 2530 - 2537